Rhabdomyosarcoma

On this page

RMS Primer - Tiny Tumors

  • Definition: A malignant mesenchymal tumor characterized by rhabdomyoblastic differentiation (cells resembling striated muscle).
  • Epidemiology: The most common soft tissue sarcoma in children.
  • Peak Incidence: Bimodal distribution, with peaks at 2-6 years and 14-18 years.
  • Associated Syndromes: Li-Fraumeni syndrome, NF1, Beckwith-Wiedemann syndrome, Costello syndrome.

⭐ Rhabdomyosarcoma is the most common soft tissue sarcoma in children.

RMS Patho & Types - Cellular Culprits

  • Origin: Primitive mesenchymal cells (skeletal muscle lineage).
  • Histological Subtypes:
    • Embryonal (ERMS): ~60-70%, better prognosis. Variants: Botryoid (best prognosis), Spindle cell (includes Sclerosing RMS).
    • Alveolar (ARMS): ~20-30%, worse prognosis. Translocations: t(2;13) PAX3-FOXO1 (commoner, poorer), t(1;13) PAX7-FOXO1.
    • Pleomorphic: Rare in children.

⭐ Alveolar RMS: PAX-FOXO1 fusions; t(2;13) PAX3-FOXO1 (common, aggressive). Histopathology of Rhabdomyosarcoma Subtypesoka

RMS Sites & Signs - Location Clues

Presentation: Often painless mass; varies by site.

Favorable Sites:

  • Orbit: Proptosis, diplopia.
  • Non-parameningeal Head & Neck (H&N): Painless mass.
  • GU (non-Bladder/Prostate): Paratesticular, vaginal, uterine masses.

Unfavorable Sites:

  • Parameningeal H&N (nasopharynx, middle ear, paranasal sinuses): Cranial nerve palsies, proptosis; CSF spread risk.
  • Bladder/Prostate: Hematuria, obstruction.
  • Extremities/Trunk: Swelling, pain.

⭐ Sarcoma botryoides (embryonal RMS variant): grape-like mass in vagina/bladder.

Common sites of Rhabdomyosarcomaoka

RMS Diagnosis & Staging - Pinpointing the Foe

  • Biopsy: Essential (incisional/excisional/core). Histopathology + IHC.
  • IHC Markers: Desmin, Myogenin (Myf4), MyoD1 (Myf3) - highly specific.
  • Imaging:
    • Primary: MRI (preferred), CT.
    • Metastasis: CT Chest, PET-CT, Bone scan.
  • Staging Workup: Bone marrow aspiration & biopsy. CSF cytology (parameningeal).
  • Staging Systems: IRS Clinical Group (I-IV), TNM Pre-treatment.

    ⭐ Myogenin and MyoD1 are nuclear transcription factors crucial for myogenic differentiation and are highly specific immunohistochemical markers for RMS.

RMS Treatment - Multimodal Attack

  • Standard: Aggressive multimodal therapy (Chemotherapy, Surgery, Radiotherapy).
  • Risk-adapted strategy guides intensity: Low, Intermediate, High-risk groups.
  • Chemotherapy:
    • Core: VAC (Vincristine, Actinomycin D, Cyclophosphamide) or IVA.
    • High-risk: Dose intensification.
  • Surgery: Wide local excision aiming for negative margins. Organ preservation is key.
  • Radiotherapy (RT): Crucial for local control, especially if unresectable or positive margins. Proton therapy considered.

⭐ VAC (Vincristine, Actinomycin D, Cyclophosphamide) is the cornerstone chemotherapy regimen.

RMS Prognosis & Genetics - Future Outlook

  • Overall survival: ~70-80%; varies by risk group.
  • Key Prognostic Factors:
    • Histology: Embryonal (favorable) vs. Alveolar (unfavorable).
    • Site: Favorable (e.g., orbit) vs. Unfavorable.
    • Stage & IRS Group (resectability, extent).
    • Age: <1 yr or >10 yrs may have worse outcomes.
    • Response to initial therapy.
  • Genetics:

    ⭐ PAX3-FOXO1 fusion (esp. in Alveolar RMS) = poor prognosis.

  • Long-term sequelae: Growth impairment, endocrine dysfunction, secondary malignancies (↑ risk).

High‑Yield Points - ⚡ Biggest Takeaways

  • Most common pediatric soft tissue sarcoma; bimodal age peak (2-6 yrs, teens).
  • Key sites: Head & Neck (orbit, parameningeal), Genitourinary (sarcoma botryoides), Extremities.
  • Embryonal (common, better prognosis) vs. Alveolar (aggressive, PAX-FOXO1 fusion).
  • Histologically a "small round blue cell tumor".
  • Multimodal therapy (surgery, chemotherapy, radiotherapy) is standard.
  • Parameningeal sites: high CNS extension risk, mandating CNS evaluation.
  • Prognosis: Alveolar histology worse; depends on site, stage, resectability.

Practice Questions: Rhabdomyosarcoma

Test your understanding with these related questions

The most common type of rhabdomyosarcoma is

1 of 5

Flashcards: Rhabdomyosarcoma

1/9

The most common extra-cranial solid neoplasm in children is _____

TAP TO REVEAL ANSWER

The most common extra-cranial solid neoplasm in children is _____

Neuroblastoma

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial